Authors
Latest:
Peii Chen, PhD: Addressing Spatial Neglect After StrokeThe senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.
Latest:
Register Today for the 2025 CMSC Annual Meeting in Phoenix!Move fast—April 30, 2025, is the final day to take advantage of early bird savings!
Latest:
John Corboy, MD: The DISCO-MS TrialThe professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.
Latest:
Neurology on the Hill: My Role as an Advocate for NeurologyNeuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.
Latest:
Steve Chung, MD: Cannabidiol in Tuberous Sclerosis ComplexThe neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.
Latest:
Karen J. Nolan, PhD: Functional Implementation of Robotics in NeurorehabilitationThe senior research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation spoke to the research being done into the functional implementation of exoskeletons in neurorehabilitation.
Latest:
Shaun Hussain, MD, MS: Exploring the Connection Between Autism and Infantile SpasmsThe director of Infantile Spasms Program at UCLA Mattel Children’s Hospital discussed why learning more about patients with infantile spasms may lead to further breakthroughs on the origins of autism spectrum disorder.
Latest:
Treatment Challenges for Migraine During Pregnancy: Brian Grosberg, MD, FAHSThe medical director of the Hartford healthcare Headache Center in Connecticut discussed the significance of findings from a study assessing migraine during pregnancy. [WATCH TIME: 4 minutes]
Latest:
Jerome Engel, Jr., MD, PhD on Referring Patients to Epilepsy CentersThe Director of the UCLA Seizure Disorder Center explained the importance of referring patients with seizures to epilepsy centers.
Latest:
Shai Efrati, MD: Assessing Hyperbaric Oxygen Therapy for NeurodegenerationThe director of the Sagol Center for Hyperbaric Medicine and Research at Yitzhak Shamir Medical Center offers takeaways on hyperbaric oxygen therapy.
Latest:
Managing Psychosis in Parkinson Disease: Challenges and OpportunitiesAlthough the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.
Latest:
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
Latest:
Thomas Leist, MD: Resetting the Immune System With CladribineThe director of the Comprehensive Multiple Sclerosis Center at Thomas Jefferson University discussed the concept of lymphocyte depletion to reset the immune system.
Latest:
Episode 139: Sleep and Seizures: Emerging Insights From AAN 2025Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Nancy Foldvary-Schaefer, DO, FAAN. [LISTEN TIME: 25 minutes]
Latest:
Overviewing Design and Topline Data From Phase 3 APOLLOE4 Study of Valiltramiprosate in Alzheimer Disease: Anton Porsteinsson, MDThe director of the Alzheimer’s Disease Care, Research, and Education Program at the University of Rochester provided clinical insight on a pivotal trial testing a novel therapeutic in patients with Alzheimer disease who are carriers of APOE4/4. [WATCH TIME: 7 minutes]
Latest:
NeuroVoices: Fred Lublin, MD, on Shifting From Phenotypes to Spectrum-Based Perspectives to Advance Multiple Sclerosis CareThe director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai talked about how modern advances research have helped transition the understanding of multiple sclerosis from fixed phenotypes to a dynamic spectrum.
Latest:
Meet & Greet: Pediatric Epilepsy Research ConsortiumM. Scott Perry, MD, an expert in epileptic disorders and board president of PERC, provided insights on the group's mission and goals, its structure and membership, and its 60+ ongoing research projects.
Latest:
Richard Rudick, MD: The CogEval App in Clinical PracticeThe goal of the free application is to make cognitive assessments routine in multiple sclerosis treatment.
Latest:
Isabelle Lambert, MD: Spike, Spindle Frequency in Hippocampus During NREM Affect Long-Term MemoryImpairment of physiological spindle activity in the hippocampus during NREM sleep by interictal epileptic activities may have negative consequences on long-term memory consolidation.
Latest:
Annette Langer-Gould, MD, PhD: Lowering Postpartum MS Relapse Rates With BreastfeedingThe regional lead in clinical and translational neuroscience at Kaiser Permanente discussed subgroup findings from a study of pregnancy in women with MS which suggested that breastfeeding in the postpartum period can drastically decrease the risk of disease relapse.
Latest:
Partnering Clinicians With Parents as a Motivator for Pediatric Epilepsy Research: Zachary Grinspan, MD, MSThe pediatric epilepsy specialist at Weill Cornell Medicine in New York City spoke on how meetings such as the 2022 AES Conference bring clinicians together as well as how parents motivate them to advance pediatric epilepsy research. [WATCH TIME: 6 minutes]
Latest:
Study Findings Provide New Hope for Patients With Multiple SclerosisMultiple sclerosis affects nearly 3 million patients worldwide; new research is helping pave the way for developing new therapies and medications that get at the defining mechanisms that trigger immune regulation loss of this unpredictable central nervous system disease.
Latest:
Jeffrey L. Cummings, MD, ScD: Optimal Therapeutic Targets for Addressing Alzheimer DiseaseThe director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair of the department of brain health at the University of Nevada Las Vegas spoke about therapies under investigation for the treatment of Alzheimer disease.
Latest:
Eva Winnebeck, PhD: Temporal Dynamics of SleepThe postdoctoral scientist spoke about an actimetry-based method studying the clinical relevance of temporal dynamics of sleep to make the dynamics easily quantifiable in everyday context.
Latest:
Aducanumab's Unlikely Road to the FDA: Is Approval Imminent?Recent news that the FDA has granted the fastest possible review for Biogen’s Alzheimer disease treatment aducanumab may be indicative of the agency’s increasing confidence in the drug.
